Serum levels of copeptin, C-reactive protein and cortisol in different severity groups of sickle cell anaemia

Nigerian Journal of Physiological Sciences

Volumn 28, Issue 2, 2013, Pages 159-164

  Akinlade, K S ^a   Atere, A D ^a   Rahamon, S K ^a   Olaniyi, J A ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Copeptin; Cortisol; Severity score; Sickle cell anaemia; Systolic blood pressureVaso occlusive crisis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; GLYCOPEPTIDE; HYDROCORTISONE;

ADULT; ANEMIA, SICKLE CELL; BLOOD; BLOOD PRESSURE; BLOOD TRANSFUSION; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD TRANSFUSION; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPEPTIDES; HUMANS; HYDROCORTISONE; LEUKOCYTE COUNT; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84925545152     PISSN: 0794859X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Akinlade K.S., Atere A.D., Olaniyi J.A., Rahamon S.K., Adewale C.O. (2013). Serum copeptin and cortisol do not accurately predict sickle cell anaemia vaso-occlusive crisis as C-reactive protein. PLoS One 4;8(11):e77913
2. Ahmed S.G. (2011). The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease. Mediterr. J. Hematol. Infect. Dis. 3(1):e2011028
3. Akinbami A., Dosunmu A., Adediran A., Oshinaike O., Adebola P., Arogundade O. (2012). Haematological values in homo-zygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Research Notes 5: 396
4. Akohoue S.A., Shankar S., Milne G.L., Morrow J., Chen K.Y., Ajayi W.U., Buchowski M.S. (2007). Energy expenditure, inflammation and oxidative stress in steady-state adolescents with sickle cell anaemia. Pediatr. Res. 61: 233-238
5. Anie K.A., Egunjobi F.E., Akinyanju O.O. (2010). Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting. Globalization and Health 6: 1-6
6. Barden E.M., Kawchak D.A., Ohene-Frempong K., Stallings V.A., Zemel B.S. (2002). Body composition in children with sickle cell disease. Am. J. Clin. Nutr. 76(1):218-225
7. Buchanan G.R., Glader B.E. (1978). Leukocyte counts in children with sicklecell disease. Comparative values in the steady state, vaso-occlusive crisis, and bacterial infection. Am. J. Dis. Child 132(4):396-398
8. Cheesbrough M. (2000). PCV and red cell indices. In: District Laboratory Practice in Tropical Countries, Part 2, Cambridge University Press, pp 309-313
9. Covitz W., Espeland M., Gallagher D., Hellenbrand W., Leff S., Talner N. (1995).The heart in sickle cell anemia. The cooperative Study of Sickle Cell Disease (CSSCD). Chest 108(5):1214-1219
10. DeBaun M.R., Sarnaik S.A., Rodeghier M.J., Minniti C.P., Howard T.H., Iyer R.V., Inusa B., Telfer P.T., Kirby-Allen M., Quinn C.T., Bernaudin F. Airewele G., Woods G.M., Panepinto J.A., Fuh B., Kwiatkowski J.K., King A.A., Rhodes M.M., Thompson A.A., Heiny M.E., Redding-Lallinger R.C., Kirkham F.J., Sabio H, Gonzalez C.E., Saccente S.L., Kalinyak K.A., Strouse J.J., Fixler J.M., Gordon M.O., Miller J.P., Noetzel M.J., Ichord R.N., Casella J.F. (2012). Associated risk factors for Silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative High systolic blood pressure. Blood 119(16):3684-3690
11. Hedo C.C., Aken'ova Y.A., Okpala I.E., Durojaiye A.O., Salimonu L.S. (1993). Acute phase reactants and severity of homozygous sickle cell disease. Journal of Internal Medicine 233: 467-470
12. Ilesanmi O.O. (2010). Pathological basis of symptoms and crises in sickle cell disorder: implications for counselling and psychotherapy. Hematol. Rep. 2(1):e2
13. Katan M., Morgenthaler N., Widmer I., Puder J.J., König C., Müller B., Christ-Crain M. (2008). Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro. Endocrinol. Lett. 29(3):341-346
14. Katan M., Christ-Crain M. (2010). The stress hormone copeptin: a new prognostic biomarker in acute illness. Eur. J. Med. Services 140: 13101
15. Kotila T., Ocheni S. (2005). Acute Painful Crisis In Sickle Cell Disease: Severity Assessment. The Internet Journal of Tropical Medicine Volume 3 Number 1
16. Marik P.E., Zaloga G.P. (2002). Adrenal insufficiency in the critically ill. A new look at an old problem. Chest 122; 1784-1796
17. Makani J., Cox S.E., Soka D., Komba A.N., Oruo J., Mwamtemi H., Magesa P., Rwezaula S., Meda E., Mgaya J., Lowe B., Muturi D., Roberts D.J., Williams T.N., Pallangyo K., Kitundu J., Fegan G., Kirkham F.J., Marsh K., Newton C.R. (2011). Mortality in sickle cell anaemia in Africa: a prospective cohort study in Tanzania. PLoS One 6(2):e14699
18. Milhorat A.T. (1942). Leucocytosis during various emotional states. Arch. Neurol. Psych. 47:779
19. Mohammed F.A., Mahdi N., Sater M.A., Al-Ola K., Almawi W.Y. (2010). The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease. Blood Cells Mol. Dis. 45(4): 293-296
20. Nickel C.H., Bingisser R., Morgenthaler N.G. (2012). The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Medicine 10: 7
21. Omoti C.E. (2005). Haematological values in sickle cell anaemia in steady state and during vaso-occlusive crises in Benin City, Nigeria. Ann. Afr. Med. 4(2): 62-67
22. Osifo B.O., Lukambi F.A., Adekile A. (1988). Plasma cortisol in sickle cell disease. Acta. Haematol. 79:44-45
23. Pegelow C.H., Colangelo L., Steinberg M., Wright E.C., Smith J., Phillips G., Vichinsky E. (1997). Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am. J. Med. 102(2):171-177
24. Platt O.S., Brambilla D.J., Rosse W.F. (1994). Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330: 1639-1644
25. Rao S.S., Goyal J.P., Raghunath S.V., Shah V.B. (2012). Hematological profile of sickle cell disease from South Gujarat, India. Hematol. Rep. 4(2):e8
26. Raphael R.I., Vichinsky E.P. (2005). Patho-physiology and treatment of sickle cell disease. Clin. Adv. Hematol. Oncol. 3: 492-505
27. Sanya A.O., Obakin O.O. (1999). Cardio-pulmonary response of patients with sickle cell anaemia disease to exercise test. Nigerian Quarterly Journal of Hospital Medicine 9(3): 172-176
28. Schultz D.R., Arnold P.I. (1990). Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, glycoprotein and fibrinogen. Seminars in Arthritis and Rheumatism 20: 129-147
29. Singhal A., Davies P., Sahota A., Thomas P.W., Serjeant G.R. (1993). Resting metabolic rate in homozygous sickle cell disease. Am. J. Clin. Nutr. 57:32-34
30. Singhal A., Davies P., Wierenga K.J., Thomas P., Serjent G. (1997). Is there an energy deficiency in homozygous sickle cell disease? Am. J. Clin. Nutr. 66: 386-390
31. World Health Organisation. (2006). Management of birth defects and haemoglobin disorders: report of a joint WHO-March of Dimes Meeting.Geneva: World Health Organisation